H. Huang
3 Papers
H. Huang is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has co-authored 3 publications.
Chat about Author
Papers
Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transpla
Yishan Ye,Myriam Labopin,Jia Chen,Zafer Gulbas,Xi Zhang,Yener Koc,Didier Blaise,Fabio Ciceri,Emmanuelle Polge,Mohamed Houhou,Lin Li,Yi Luo,Depei Wu,H. Huang,Mohamad Mohty,Norbert-Claude Gorin +15 more
TL;DR: In this paper , patients with acute myelogenous leukemia (AML) or acute lymphocytic leukemia (ALL) in the European Society for Blood and Marrow Transplantation (EBMT) registry were analyzed.
3
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.
Hui-Sheng Ai,Nelson J. Chao,David A. Rizzieri,Xiaojun Huang,Thomas R. Spitzer,Jianxiang Wang,Mei Guo,Armand Keating,Elizabeth F. Krakow,Didier Blaise,Jun Ma,Depei Wu,John L. Reagan,Usama Gergis,Rafael F. Duarte,Preety Chaudhary,Kai-Xun Hu,Chang-Lin Yu,Qi-Yun Sun,Ephraim J. Fuchs,B Cai,Ya-Jing Huang,Jia Qiao,David Gottlieb,Kirk R. Schultz,Mingyao Liu,Xiequn Chen,Wenming Chen,Jianmin Wang,Xiao-Hui Zhang,Jianyong Li,H. Huang,Zimin Sun,Fei Li,Linhua Yang,Lian-sheng Zhang,Lijuan Li,Kaiyan Liu,Jie Jin,Qifa Liu,Daihong Liu,Chun Ji Gao,Chuanbo Fan,Li Wei,Xi Zhang,Liangding Hu,Weijing Zhang,Yuyang Tian,Weidong Han,Jun-Ming Zhu,Zhijian Xiao,Daobin Zhou,Bolong Zhang,Yongqing Zhang,Xiaoxiong Wu,Xu-Liang Shen,Xuzhang Lu,Xinrong Zhan,Xiuli Sun,Yi Xiao,Jing Wang,Xiaoding Shi,Bo Zheng,Jie Chen,Banghe Ding,Zhao Wang,Fang Zhou,Meixiang Zhang,Yizhuo Zhang,Jie Sun,Bing Xia,Baoan Chen,Liang-Min Ma +72 more
TL;DR: In this paper , the International Microtransplant Interest Group provides recommendations and considerations for microtransplant in the treatment of elderly acute myeloid leukemia (EAML), and four major issues related to MST for treating EAML were addressed: therapeutic principle of MST, candidates for MST (1), induction chemotherapy regimens (3), and post-remission therapy based on MST.
2
A phase 1 study evaluating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of Bcl-2 inhibitor BGB-11417 in adult patients with mature B-cell malignancies.
Caixia Li,Jia Wei,Keshu Zhou,Peng Li,H. Huang,Fei Li,Qingqing Cai,Yujun Dong,Shenmiao Yang,Huilin Zhou,Xinyou Zhang,Lu Zhang,Zaixing Shi,Zhiyu Liang,Binghao Wu,Depei Wu +15 more
TL;DR: In this article , the authors presented the results of BGB-11417 monotherapy in B-cell malignancies with a longer follow-up, showing that the monotherapy was well tolerated at all tested doses up to 640 mg/d, with no dosedependent toxicity increase.
1